Glycans in Diseases and Therapeutics

Glyco-epitope diversity enhances the role of glycans and is now considered essential for life, both under normal and pathological conditions. The vital role of glycans in the research and development of diseases and the possible therapeutic use of this class of molecules by describing how the interaction of glycans with growth factors, extracellular proteases ,growth factor binding proteins, protease inhibitors, chemokines, morphogens, and adhesive proteins regulates inflammation, infection, atherosclerosis,  cancer, thrombosis and embryonic stem cell biology.

  • Genetic disorder of glycosylations
  • Growth factors and oncogenes
  • Glycoprotein ligand
  • Genetically engineered glycan

Related Conference of Glycans in Diseases and Therapeutics

February 12-13, 2018

Glycobiology Biochem Conference 2018

Paris, France
September 17-18, 2018

34th International Conference on Chemical Biology & Radiation Therapy

San Diego, California
July 23-24 , 2018

International Conference of Forensic Research & Technology

Melbourne , Australia
August 06-07, 2018

International Conference on Structural Biology

Dubai, UAE
August 27-28, 2018

5th International Conference on Glycobiology

Toronto, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
September 10-11, 2018

International Conference on Nutritional Biochemistry

Prague, Czech Republic
October 17-18, 2018

2nd International Meeting on Global Proteomics Conference

Seoul ,South Korea
November 29-30, 2018

Bioinformatics Congress 2018

Dublin, Ireland

Glycans in Diseases and Therapeutics Conference Speakers